Anastrozole: prices and alternatives
Indicated as adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. Also indicated as first-line treatment for hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer in postmenopausal women, and for advanced breast cancer after…
5 products with this active ingredient from 5 manufacturers. Official prices from 330 to 706 EGP.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.




